Biological Function of Dreaming in Dreaming and Non-Dreaming Patients With PCA Infarction

NCT04749992 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 142

Last updated 2024-03-12

No results posted yet for this study

Summary

This study is a quasi-experimental between-group design. Using a prospective two-arm controlled exploratory study, data will be collected on an initial assessment of the effects of a specific neurological sample after thrombotic infarction (PCA infarction) who lost the ability to dream due to the infarction (experimental group) compared to a specific neurological sample after thrombotic infarction (PCA infarction) without loss of the ability to dream (comparison group) in terms of subjective and objective sleep quality and memory consolidation. Besides the importance to further elucidate the role of dreaming for sleep architecture and memory consolidation, the results of the evaluation are of great clinical relevance in a further scientific investigation regarding the treatment of a specifically neurological sample with acute thrombotic infarction.

Conditions

  • Dream Disorder
  • Thrombotic Infarction
  • PCA Infarct

Interventions

PROCEDURE

Polysomnographic examination in sleep laboratory (PSG measurement)

Recording of sleep quality and quantity by sleep parameters, such as total sleep time - TST; duration of sleep stages - S1t, S2t, S3t, rapid eye movement - REMt; sleep onset latency - SL; wake after sleep onset - WASO, sleep efficiency - SE.

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    collaborator OTHER
  • International Psychoanalytic University Berlin

    lead OTHER

Principal Investigators

  • Tamara Fischmann, Prof. · International Psychoanalytic University

  • Michael Koslowski, Dr. · Charite university medicine

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2024-03-08
Completion
2024-03-08

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04749992 on ClinicalTrials.gov